vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 13.0%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FCF vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $75.5M |
| Net Profit | $37.5M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 28.1% | — |
| Revenue YoY | 13.0% | 27.7% |
| Net Profit YoY | 14.8% | — |
| EPS (diluted) | $0.37 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $75.5M | ||
| Q3 25 | $136.0M | $54.5M | ||
| Q2 25 | $131.0M | $52.4M | ||
| Q1 25 | $118.0M | $46.0M | ||
| Q4 24 | $120.4M | $59.1M | ||
| Q3 24 | $121.2M | $80.5M | ||
| Q2 24 | $120.2M | $47.1M |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | — | ||
| Q3 25 | $41.3M | $8.8M | ||
| Q2 25 | $33.4M | $5.9M | ||
| Q1 25 | $32.7M | $3.0M | ||
| Q4 24 | $35.8M | — | ||
| Q3 24 | $32.1M | $20.3M | ||
| Q2 24 | $37.1M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 22.7% | ||
| Q3 25 | 38.1% | 17.6% | ||
| Q2 25 | 32.1% | 12.7% | ||
| Q1 25 | 34.8% | 8.7% | ||
| Q4 24 | 37.1% | 22.6% | ||
| Q3 24 | 33.4% | 27.4% | ||
| Q2 24 | 38.7% | -4.6% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | — | ||
| Q3 25 | 30.4% | 16.2% | ||
| Q2 25 | 25.5% | 11.2% | ||
| Q1 25 | 27.7% | 6.5% | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 26.5% | 25.2% | ||
| Q2 24 | 30.9% | -9.6% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $0.26 | ||
| Q3 25 | $0.39 | $0.17 | ||
| Q2 25 | $0.32 | $0.12 | ||
| Q1 25 | $0.32 | $0.06 | ||
| Q4 24 | $0.35 | $0.40 | ||
| Q3 24 | $0.31 | $0.41 | ||
| Q2 24 | $0.36 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $154.9M | $22.7M |
| Stockholders' EquityBook value | $1.6B | $130.3M |
| Total Assets | $12.3B | $216.3M |
| Debt / EquityLower = less leverage | 0.10× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | $22.7M | ||
| Q3 25 | $262.1M | $34.0M | ||
| Q2 25 | $262.4M | $45.3M | ||
| Q1 25 | $262.7M | $56.7M | ||
| Q4 24 | $263.0M | $68.0M | ||
| Q3 24 | $136.3M | $79.3M | ||
| Q2 24 | $136.6M | $90.7M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.4B | $97.1M | ||
| Q4 24 | $1.4B | $92.1M | ||
| Q3 24 | $1.4B | $71.1M | ||
| Q2 24 | $1.4B | $48.5M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $216.3M | ||
| Q3 25 | $12.3B | $202.9M | ||
| Q2 25 | $12.2B | $194.9M | ||
| Q1 25 | $11.8B | $196.2M | ||
| Q4 24 | $11.6B | $213.3M | ||
| Q3 24 | $12.0B | $220.7M | ||
| Q2 24 | $11.6B | $205.0M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | 0.17× | ||
| Q3 25 | 0.17× | 0.30× | ||
| Q2 25 | 0.17× | 0.43× | ||
| Q1 25 | 0.18× | 0.58× | ||
| Q4 24 | 0.19× | 0.74× | ||
| Q3 24 | 0.10× | 1.12× | ||
| Q2 24 | 0.10× | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $14.4M | ||
| Q3 25 | $49.5M | $9.7M | ||
| Q2 25 | $30.4M | $14.1M | ||
| Q1 25 | $55.9M | $3.6M | ||
| Q4 24 | $129.5M | $15.6M | ||
| Q3 24 | $53.6M | $11.0M | ||
| Q2 24 | $22.7M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $113.9M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 94.6% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 12.9% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | — | ||
| Q3 25 | 1.20× | 1.10× | ||
| Q2 25 | 0.91× | 2.41× | ||
| Q1 25 | 1.71× | 1.21× | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 1.67× | 0.54× | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
